Czech National Bank’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154M Buy
355,960
+15,863
+5% +$4.82M 0.84% 20
2026
Q1
$72.7M Buy
340,097
+8,900
+3% +$1.99M 0.48% 34
2025
Q4
$56.7M Buy
331,197
+9,755
+3% +$1.52M 0.37% 44
2025
Q3
$43M Buy
321,442
+8,781
+3% +$930K 0.3% 58
2025
Q2
$30.4M Buy
312,661
+17,824
+6% +$1.41M 0.24% 85
2025
Q1
$21.4M Buy
294,837
+15,858
+6% +$1.25M 0.2% 105
2024
Q4
$20.2M Buy
278,979
+13,389
+5% +$1.02M 0.19% 98
2024
Q3
$21.7M Buy
265,590
+16,450
+7% +$1.43M 0.22% 92
2024
Q2
$26.5M Buy
249,140
+18,470
+8% +$1.77M 0.3% 61
2024
Q1
$22.4M Sell
230,670
-190
-0.1% -$16.7K 0.29% 68
2023
Q4
$18.1M Sell
230,860
-2,110
-0.9% -$144K 0.26% 82
2023
Q3
$14.6M Buy
232,970
+73,930
+46% +$4.86M 0.23% 93
2023
Q2
$10.2M Buy
159,040
+80
+0.1% +$4.51K 0.23% 91
2023
Q1
$8.43M Sell
158,960
-670
-0.4% -$32.9K 0.21% 105
2022
Q4
$6.71M Buy
159,630
+570
+0.4% +$23.8K 0.18% 125
2022
Q3
$5.82M Buy
+159,060
New +$7.08M 0.17% 131

Other funds holding LRCX

Czech National Bank's LRCX Position: Q2 2026 in Review

Czech National Bank increased its Lam Research (LRCX) stake by 4.7% in Q2 2026, buying an estimated $4.82M and bringing the position to 355,960 shares worth $154M. The position accounts for 0.84% of the portfolio, ranked #20.

Czech National Bank first reported a position in LRCX in Q3 2022 and has held it in 16 quarters since. 1,282 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Czech National Bank held 355,960 shares of Lam Research worth $154M as of Q2 2026.
  • Czech National Bank bought 15,863 Lam Research shares in Q2 2026, an estimated $4.82M.
  • Lam Research made up 0.84% of Czech National Bank's portfolio in Q2 2026, its #20 holding.
  • Czech National Bank first reported a position in Lam Research in Q3 2022 and has held it in 16 quarters since.
  • 1,282 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.